Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme
Bahl, A Masson, S Malik, Z Birtle, A Sundar, S Jones, R James, N Mason, M Kumar, S Bottomley, D
Bahl, A
Masson, S
Malik, Z
Birtle, A
Sundar, S
Jones, R
James, N
Mason, M
Kumar, S
Bottomley, D
Citations
Altmetric:
Abstract
To compile the safety profile and quality of life (QoL) data for patients with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel in the UK Early Access Programme (UK EAP).
Affiliation
Description
Date
2015-12
Publisher
Collections
Keywords
Type
Article
Citation
Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279). 2015, 116 (6):880-7 BJU Int